Fortis Malar Hospitals Limited

Equities

FORTISMLR6

INE842B01015

Healthcare Facilities & Services

Market Closed - Bombay S.E. 11:00:57 28/06/2024 BST 5-day change 1st Jan Change
63.97 INR -1.99% Intraday chart for Fortis Malar Hospitals Limited -9.57% +8.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Fortis Malar Hospitals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Fortis Malar Hospitals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Fortis Malar Hospitals Limited Announces Executive Appointments CI
Fortis Malar Hospitals Limited Proposes Final Dividend for the Year Ended March 31, 2024 CI
Fortis Malar Hospitals Limited Appoints Ramesh Lakshman Adige as Additional Director (Non- Executive, Non-Independent Director), Effective May 6, 2024 CI
Fortis Malar Hospitals Limited Approves Declaration of Interim Dividend CI
Fortis Malar Hospitals Board to Conisder Interim Dividend for Fiscal 2024 MT
Fortis Malar Hospitals Limited Announces Resignation of Sandeep Singh as Company Secretary & Compliance Officer CI
Fortis Malar Hospitals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
MGM Healthcare Private Limited completed the acquisition of Entire business operations of Fortis Malar Hospital, Chennai from Fortis Malar Hospitals Limited. CI
MGM Healthcare Private Limited entered into a definitive agreement to acquire Entire business operations of Fortis Malar Hospital, Chennai from Fortis Malar Hospitals Limited for approximately INR 450 million. CI
Fortis Malar Hospitals Limited Approves the Appointment of Ms. Richa Singh Debgupta as an Additional Director (Non-Executive & Non-Independent) with Effect from October 10, 2023 CI
Fortis Malar Hospitals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Fortis Malar Hospitals Limited Announces Resignation of Dr. Nithya Ramamurthy as Director CI
Fortis Malar Hospitals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Fortis Malar Hospitals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Fortis Malar Hospitals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Fortis Malar Hospitals Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Fortis Malar Hospitals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Fortis Malar Hospitals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Fortis Malar Hospitals Limited Appoints Chandrasekar Ramasamy as Whole Time Director CI
Fortis Malar Hospitals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Fortis Malar Hospitals Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Fortis Malar Hospitals Limited Announces Executive Changes CI
Fortis Malar Hospitals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Chart Fortis Malar Hospitals Limited
More charts
Fortis Malar Hospitals Limited is an India-based company, which is a provider of super specialty and multi-specialty healthcare services. The Company focuses on providing medical care in various areas, such as cardiology and cardiac surgery, neurosurgery, gynecology, orthopedics, gastroenterology, neurology, pediatrics, diabetics, nephrology, and internal medicine. It is engaged in establishing hospitals and clinics to conduct healthcare for the society in various branches of medicine, such as cardiac sciences, endocrine surgery, geriatric medicine, mental health and behavioral sciences, liver transplant and hepatobiliary sciences, oncology, neurology, dental science, medical genetics, pain and palliative medicine, dermatology, diabetology/endocrinology, emergency and trauma, endocrine surgery, ears, nose and throat (ENT), gastroenterology and hepatobiliary sciences, general surgery, hematology, infectious diseases, neurosurgery, obstetrics and gynecology, organ transplant, pediatrics.
More about the company
  1. Stock Market
  2. Equities
  3. FORTISMLR6 Stock
  4. News Fortis Malar Hospitals Limited
  5. Fortis Malar Hospitals Board to Conisder Interim Dividend for Fiscal 2024